Both in Pharmaceuticals
Inovio Pharmaceuticals vs ALX Oncology Holdings
Over the past year INO returned −33.6% and ALXO returned −17.8%; their daily moves had a correlation of 0.20.
INO −33.6% ALXO −17.8%Growth of $1, one year, split-adjusted
| Metric | INO | ALXO |
|---|---|---|
| Price | $1.66 | $1.29 |
| Market cap | $171.6M | $178.4M |
| Today | −12.17% | −5.84% |
| 1 month | +44.3% | +6.6% |
| 6 months | +45.6% | −33.2% |
| Year to date | −4.6% | +14.2% |
| 1 year | −29.4% | −16.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $36.7M | $128.5M |
| Dividend yield | — | — |
| Volatility (60d) | 261.1% | 93.1% |
| Short % of float | 26.3% | 6.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).